Estimation of absorbed dose to the kidneys in patients after treatment with (177)Lu-octreotate: comparison between methods based on planar scintigraphy

BACKGROUND: Lu-[DOTA(0), Tyr(3)]-octreotate ((177)Lu-octreotate) is used to treat neuroendocrine tumors with high somatostatin-receptor expression. (177)Lu-octreotate is mainly excreted via the kidneys, but to some extent, accumulates in the kidney cortex due to, e.g., tubular reabsorption. Renal to...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Larsson, Maria, Bernhardt, Peter, Svensson, Johanna B, Wängberg, Bo, Ahlman, Håkan, Forssell-Aronsson, Eva
Formato: Artigo
Idioma:Inglês
Publicado: Springer 2012
Assuntos:
Original Research
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC3506567/
https://ncbi.nlm.nih.gov/pubmed/23006939
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/2191-219X-2-49
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares